홈
탐색
nav.journalClub
트렌드
더보기
synapse
⌘+K
언어
한국어
한국어
March 3, 2026
Advantages and limitations of the inclusion of ascorbic acid on nitrosamine mitigation in pharmaceutical drug products
AM
Armen H. Mekhdjian
MS
Morteza Sarmadi
IO
Isabel Olson
See all
Key Points
Ascorbic acid effectively reduces nitrosamines, improving drug product safety and stability.
The study noted a significant decrease in nitrosamine levels, with a 50% reduction after ascorbic acid incorporation.
Assessment of the impact on stability and reactivity was carried out using controlled experiments.
These findings may indicate potential improvements in pharmaceutical formulations for broader applications.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Mekhdjian et al. (Thu,) studied this question.
synapsesocial.com/papers/69a7679cbadf0bb9e87e1a39
https://doi.org/https://doi.org/10.1016/j.xphs.2026.104190
Advantages and limitations of the inclusion of ascorbic acid on nitrosamine mitigation in pharmaceutical drug products | Synapse